Small molecule inhibitors targeting the cancers
Abstract Compared with traditional therapies, targeted therapy has merits in selectivity, efficacy, and tolerability. Small molecule inhibitors are one of the primary targeted therapies for cancer. Due to their advantages in a wide range of targets, convenient medication, and the ability to penetrat...
Saved in:
| Main Authors: | Gui‐Hong Liu, Tao Chen, Xin Zhang, Xue‐Lei Ma, Hua‐Shan Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-12-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy
by: Shuangli Zhu, et al.
Published: (2025-05-01) -
Editorial: Exploring novel approaches to small molecule kinase inhibitors in cancer treatment
by: Anna Carbone, et al.
Published: (2025-02-01) -
Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors
by: Felix Scheuplein, et al.
Published: (2024-10-01) -
Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01) -
KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells
by: Dominic Leiser, et al.
Published: (2015-08-01)